Treatments
Medicines for Migraine Attacks vs. Prevention
Migraine attack medicines treat symptoms when an attack occurs. Preventive treatments are used on a planned schedule to reduce future migraine burden. They are complementary: successful prevention does not always eliminate the need for an attack plan. Your clinician should explain the purpose, timing, safety limits, and follow-up for each medicine rather than leaving you to decide from its name.[1]
Two goals, two kinds of treatment decisions
An attack medicine is judged by what happens during a particular episode: does it reduce pain and other symptoms, restore function, and provide lasting relief without unacceptable side effects?
A preventive treatment is judged over time: are there fewer migraine days, milder attacks, less disruption, or less need for acute medication? Looking only at the first day after starting a preventive can give a misleading impression.
These are different questions. A medicine that treats an attack well may have no role as a daily preventive. A preventive that helps substantially may not provide immediate relief during a breakthrough attack.
What medicines can treat an attack?
Clinicians may consider certain over-the-counter pain medicines, triptans, gepants, and other prescription options. Nausea treatment or a nonoral route may be important when vomiting or difficulty swallowing interferes with treatment. The choice depends on the attack pattern and the patient's medical risks.[2]
An acute plan should answer more than "take this for migraine." Ask when to take it, whether another dose is allowed, what maximum limits apply, and what to do when relief is inadequate. Those details vary by product.
Do not build a combination from leftover prescriptions. Different products may share ingredients or interact. Bring a complete list to the clinician or pharmacist, including cold medicines and combination headache products.
What medicines can prevent migraine?
Preventive options include medicines originally used for other conditions and treatments developed specifically for migraine. Examples include selected blood-pressure medicines, antiseizure medicines, antidepressants, and CGRP-targeting treatments. Botox is an option for appropriate patients with chronic migraine and is delivered through in-person injections.[5]
The original purpose of a medicine does not make it an inferior choice. A drug that also fits another health condition can sometimes be practical. Conversely, an established treatment may be a poor match because of side effects, contraindications, or pregnancy considerations.
The American Headache Society's 2024 position supports CGRP-targeting therapies as a first-line preventive option without requiring failure of older treatments. Insurer coverage rules may still impose separate requirements.[3]
When is prevention worth discussing?
The 2026 AAN/AHS guideline advises offering prevention to people with at least four migraine days per month, at least four moderate-to-severe headache days per month, or migraine that impairs work or daily activities.[1]
Frequency is only one part of the decision. A person with relatively few but prolonged, disabling attacks may need a prevention discussion. Someone who frequently needs acute medication also needs a review of the full plan and medication-overuse risk.
You do not have to wait until headaches occur every day to ask. Bring information about lost time, side effects, and uncertainty about whether your attack medicine will work.
Some medicine names appear in both categories
Rimegepant is approved for acute treatment of migraine in adults and prevention of episodic migraine in adults. The prescribed schedule depends on the intended use.[4] That does not mean you can freely switch between the schedules or add doses whenever symptoms appear.
This is a useful reason to keep a simple medicine list with a "purpose" column. If you receive instructions from more than one prescriber, ask how the plans fit together before making changes.
| Question | Attack treatment | Prevention |
|---|---|---|
| Main purpose | Address an attack happening now | Reduce future burden |
| How use is organized | According to an individualized attack plan | On a prescribed schedule |
| What to track | Relief, return of symptoms, function, and side effects | Migraine days, disability, tolerability, and use of attack medicine |
| Why reassessment matters | The timing, route, or drug may need adjustment | Benefit needs an appropriate trial and follow-up |
What makes a treatment trial meaningful?
Record what you actually used and what happened. "Did not work" may mean no pain relief, benefit that wore off, persistent nausea, or side effects that prevented use. Each leads to a different discussion.
For prevention, agree on the review point before starting. The required duration depends on the treatment and whether the prescribed regimen has been reached. Repeated gaps caused by cost or delivery delays can make it difficult to judge the medication itself.
A useful goal is concrete: fewer afternoons lost to migraine, improved attendance, or reliable relief during attacks. Your clinician may also use standardized disability questions. Small changes matter when they make the plan more sustainable.
Safety applies to both categories
Prescription and nonprescription products can have important risks. Pregnancy plans, heart and vascular disease, kidney or liver problems, allergies, and interactions all affect selection.
Targeted migraine treatment is not risk-free. For example, current rimegepant labeling includes warnings about hypersensitivity, new or worsening high blood pressure, and Raynaud's phenomenon.[4] Your own medicine's labeling and instructions should guide the safety discussion.
Contact your clinician about troublesome effects or a pattern of needing medicine more often than planned. Do not abruptly stop a regular prescription or exceed acute limits without guidance. Seek emergency care for new stroke-like symptoms or a sudden severe headache rather than treating them as a routine breakthrough attack.
Frequently asked questions
Does needing both treatments mean my migraine is unusually severe?
No. They address different goals. A combined plan may be appropriate whenever prevention helps reduce burden but attacks still occur.
Will prevention cure migraine?
The goal is improved control, not a guaranteed cure. Evaluate frequency, function, severity, and tolerability together rather than expecting every attack to disappear.[1]
Should I choose the newest medicine?
Choose with your clinician based on evidence, safety, preferences, and access. Newer and older options may both be reasonable. Price or advertising alone should not decide the plan.
For ongoing, nonurgent headaches
Learn how TeleHeadache works and whether clinician-reviewed online care may be an appropriate next step. Some symptoms require an examination, testing, or a different level of care.
This article provides general education and does not replace a personal medical evaluation. Do not delay urgent or emergency care while waiting for an online response.
References
- AAN/AHS: Updated guideline on migraine prevention medications for adults, August 31, 2026
Professional society guideline announcement · Accessed 2026-10-04 - IHS global practice recommendations for acute pharmacological treatment of migraine, 2024
International practice guideline · Accessed 2026-10-04 - AHS: CGRP-Targeting Therapies as a First-Line Option for Migraine Prevention
Professional society position statement discussion · Accessed 2026-10-04 - DailyMed: NURTEC ODT (rimegepant), current U.S. prescribing information
U.S. prescribing information, NIH DailyMed · Accessed 2026-10-04 - IHS global practice recommendations for preventive pharmacological treatment of migraine, 2024
International practice guideline · Accessed 2026-10-04
